5,6-Methylenedioxy-2-aminoindane : from laboratory curiosity to 'legal high'
Gallagher, C. T., Assi, S., Stair, J. L., Fergus, S., Corazza, Ornella, Corkery, John and Schifano, Fabrizio
(2012)
5,6-Methylenedioxy-2-aminoindane : from laboratory curiosity to 'legal high'.
pp. 106-112.
ISSN 1099-1077
The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the UK in April 2010, and almost immediately, MDAI was widely advertised as a legal alternative. This paper provides both an overview of the current state of knowledge of MDAI and a critical analysis of online available information relating to its psychoactive effects, adverse reactions and use in combination with other drugs.
Item Type | Article |
---|---|
Date Deposited | 26 Jul 2024 18:54 |
Last Modified | 26 Jul 2024 18:54 |
Downloads
Full text not available from this repository.
Explore Further
Read more research from the creator(s):
Find work associated with the faculties and division(s):
- Department of Pharmacy
- Health & Human Sciences Research Institute
- Centre for Clinical Practice, Safe Medicines and Drug Misuse Research
- Medicinal and Analytical Chemistry
- Centre for Research into Topical Drug Delivery and Toxicology
- Nanopharmaceutics
- Natural Product Chemistry and Drug Design
- School of Life and Medical Sciences
- Public Health and Patient Safety Unit
- Department of Clinical, Pharmaceutical and Biological Science
- Centre for Health Services and Clinical Research
- Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
- Centre for Hazard Detection and Protection Research
- Centre for Research in Mechanisms of Disease and Drug Discovery
- Centre for Future Societies Research